Kivexa

Kivexa Overdosage

abacavir + lamivudine

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig
Full Prescribing Info
Overdosage
No specific symptoms or signs have been identified following acute overdose with abacavir or lamivudine, apart from those listed as undesirable effects.
If overdose occurs the patient should be monitored for evidence of toxicity (see Adverse Reactions), and standard supportive treatment applied as necessary. Since lamivudine is dialysable, continuous haemodialysis could be used in the treatment of overdose, although this has not been studied. It is not known whether abacavir can be removed by peritoneal dialysis or haemodialysis.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in